Real-time enrollment status for this autoimmune hemolytic anemia clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT05648968 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Autoimmune Hemolytic Anemia |
| Phase | Clinical Trial |
| Target Enrollment | 90 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | February 13, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT05648968 is currently active_not_recruiting participants. This clinical trial study for autoimmune hemolytic anemia is not currently accepting new participants at 15 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05648968 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05648968 was last updated 2 weeks ago (February 13, 2026). HelloStudys verifies this status automatically.